Stay updated on EMPIRE CF: CTX-4430 Clinical Trial
Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page
- CheckyesterdayChange DetectedAdded revision entry v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.4.2. The previous notice about a lapse in government funding was removed and updated with current open-status information and links (cc.nih.gov and opm.gov).SummaryDifference0.3%

- Check51 days agoChange DetectedA site-wide notice was added about a lapse in government funding and the NIH Clinical Center's operation status, including potential delays in updates. The revision tag was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check58 days agoChange DetectedUI changes include showing the glossary and minor capitalization/label tweaks such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with the addition of 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedExpanded list of trial locations across US states and Canada is now displayed, clarifying where the study is conducted.SummaryDifference2%

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.